SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: An ASO-based strategy has been successfully used to enhance the expression of the WT Scn1a allele in a mouse model of Dravet syndrome in order to circumvent Nav1.1 haploinsufficiency (Han et al., 2020).